NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SomesTech Biotechnology Co., Ltd.

SomesTech Biotechnology Co., Ltd.

Private
ShenzhenHealthcare & Life Scienceshttps://somestech.com/

Last Round

Series B

Nov 3, 2023

Est. Valuation

$226M

Total Funding Raised

$28.59M

Company Overview

SomesTech Biotechnology Co., Ltd. is a biotechnology company that focuses on developing new drug nanocarriers and providing innovative solutions for drug delivery using exosome nanotechnology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug deliveryexosomesnanomedicinedrug delivery platformexosome therapeuticsexosome manufacturingCDMOdrug nanocarriersnucleic acid deliveryAI drug deliveryprotein deliverydrug delivery systemDDSbiotech equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SomesTech Biotechnology Co., Ltd. Comparables

Compare SomesTech Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

SomesTech Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Evox Therapeutics
81%
Carus Bio
76%
EXO Biologics
76%

SomesTech Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 3, 2023
Series AMar 7, 2019
SeedJan 20, 2017

SomesTech Biotechnology Co., Ltd. Investors

Notable investors and investment history

SomesTech Biotechnology Co., Ltd. investors
InvestorRounds
European Investment Bank GroupSeries B
Prevail PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 3, 2023

    $19M round with Prevail Partners and EIB.

  • Mar 7, 2019

    Raised $8M in Series A funding.

SomesTech Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SomesTech Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SomesTech Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Year Founded2022
Last FundingNov 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.